J. Douglas Warner's most recent trade in Tyra Biosciences Inc was a trade of 200,000 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on Aug. 7, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Tyra Biosciences Inc | Douglas J. Warner | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Aug 2025 | 200,000 | 200,000 | - | - | Stock Option (Right to Buy) | |
| eFFECTOR Therapeutics Inc | J. Douglas Warner | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Feb 2024 | 25,000 | 25,000 | - | - | Stock Option (Right to Buy) | |
| eFFECTOR Therapeutics Inc | Douglas J. Warner | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jan 2023 | 250,000 | 250,000 | - | - | Stock Option (Right to Buy) | |
| eFFECTOR Therapeutics Inc | Douglas J. Warner | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Aug 2022 | 618,160 | 618,160 | - | - | Stock Option (Right to Buy) |